NASDAQ · Medical - Healthcare Information Services

Simulations Plus, Inc. (SLP) Stock

$18.50 +0.00% NASDAQ: SLP Healthcare

Valuation

MetricValue
Price$18.50
Market Cap$374.16M
P/E Ratio45.14
P/B Ratio2.68
P/S Ratio4.56
EPS (TTM)$-3.22
52-Week High$21.01
52-Week Low$11.09
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE6.18%
ROA5.30%
ROCE8.25%
Gross Margin-89.87%
Operating Margin-89.87%
Net Margin9.88%
Debt/Equity0.01
Current Ratio7.43

Annual Financials (USD)

Metric20212022202320242025
Revenue$46.0M$54.0M$60.0M$70.0M$79.0M
Operating Profit$11.0M$15.0M$9.0M$6.0M$-71.0M
Net Profit$10.0M$12.0M$10.0M$10.0M$-65.0M
EPS$0.47$0.60$0.49$0.49$-3.22
Op Margin24.2%27.7%14.6%8.8%-89.3%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$182.0M$191.0M$193.0M$208.0M$132.0M
Total Liabilities$16.0M$12.0M$23.0M$25.0M$7.0M
Cash$37.0M$52.0M$58.0M$10.0M$31.0M
Borrowings$1.0M$1.0M$1.0M$1.0M$1.0M

Latest News

Simulations Plus Fiscal Q3 Adjusted Earnings Decline, Revenue Rises MT Newswires · Jul 9, 2026 Simulations Plus: Fiscal Q3 Earnings Snapshot Associated Press · Jul 9, 2026 Simulations Plus Reports Third Quarter Fiscal 2026 Financial Results Business Wire · Jul 9, 2026 [Latest] Global In Silico Clinical Trials Market Size/Share Worth USD 8.94 Billion by 2035 at a 15.2% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) GlobeNewswire · Jun 26, 2026 Simulations Plus Advances Agentic Drug Development with NVIDIA BioNeMo Agent Toolkit Business Wire · Jun 23, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$19.0M$18.0M$22.0M$13.0M$18.0M
Investing Cash Flow$-31.0M$0$3.0M$-55.0M$3.0M
Financing Cash Flow$-1.0M$-4.0M$-18.0M$-2.0M$-2.0M
Net Cash Flow$-12.0M$15.0M$6.0M$-47.0M$21.0M
Free Cash Flow$15.0M$14.0M$18.0M$13.0M$17.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.39
EV / EBITDA25.93
FCF Yield6.97%
Quick Ratio5.54
Interest Coverage—
Return 1Y38.13%
Return 3Y-61.63%
Return 5Y-57.91%

Ownership

Insiders Held17.19%
Institutions Held82.66%
Institutions Float Held99.82%
Institutional HolderSharesReport Date
First Light Asset Management, LLC2,632,8232026-03-31
Blackrock Inc.1,252,3762026-03-31
Morgan Stanley887,5112026-03-31
First Eagle Investment Management, LLC742,0692026-03-31
Vanguard Capital Management LLC739,7212026-03-31

About Simulations Plus, Inc.

Simulations Plus, Inc. is led by CEO Shawn O'Connor, employs 243 people, headquartered in US, publicly traded since 1997.

Simulations Plus, Inc. (SLP) stock trades at $18.50 with a market capitalization of $374.16M. The stock is valued at a price-to-earnings (P/E) ratio of 45.14, price-to-book of 2.68, price-to-sales of 4.56. Over the past 52 weeks the stock has ranged between $11.09 and $21.01, and currently trades 11.9% below its 52-week high.

On profitability, Simulations Plus, Inc. generates a return on equity (ROE) of 6.18%, return on capital employed of 8.25%, an operating margin of -89.87%, a net profit margin of 9.88%.

Simulations Plus, Inc. by the numbers, 2016–2025

Between 2016 and 2025 Simulations Plus, Inc. reported revenue of $20.0M rising to $79.0M, a change of +295.0% across 10 years. Compounded, revenue has grown 13.5% a year over five years, 13.5% over three, 12.9% over the last twelve months. Net profit fell to $-65.0M.

Operating margin went from 36.2% in 2016 to -89.3% in 2025, a fall of 125.5 percentage points. The most recent net margin is 9.88%. On a trailing twelve-month basis to Jun '26, revenue is $81.0M and net profit $9.0M.

Borrowings stand at $1.0M, cash from operations was $18.0M in the latest year, positive in 10 of the last 10.

Return on equity has averaged -5.6% over five years, and was -52.0% in the most recent year.

The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

Simulations Plus, Inc. (SLP) — frequently asked questions

What is Simulations Plus, Inc. (SLP) stock price today?

Simulations Plus, Inc. (SLP) is currently trading at $18.50, up 0% today.

What is SLP P/E ratio?

Simulations Plus, Inc.'s P/E ratio is 45.14. This is above the typical market average of roughly 18-22x. A high P/E often reflects higher expected earnings growth, a temporary dip in earnings, or both.

What is SLP return on equity (ROE)?

Simulations Plus, Inc.'s return on equity (ROE) is 6.18%. ROE measures net income relative to shareholders' equity. This is below the typical market range of roughly 12-15%.

What is Simulations Plus, Inc.'s market cap?

Simulations Plus, Inc. has a market capitalization of $374.16M.

Does SLP pay a dividend?

Simulations Plus, Inc. is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.

How much debt does SLP carry?

Simulations Plus, Inc. has a debt-to-equity ratio of 0.01. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.

What is SLP's profit margin?

Simulations Plus, Inc. reports a net profit margin of 9.88% — the share of revenue left after every cost, including tax and interest.

What sector is SLP in?

Simulations Plus, Inc. is classified under Healthcare, in the Medical - Healthcare Information Services industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.

Which exchange is SLP listed on?

Simulations Plus, Inc. trades on NASDAQ under the ticker SLP.

What is SLP's 52-week range?

Over the last year Simulations Plus, Inc. has traded between $11.09 and $21.01.

Related Healthcare Stocks

LLY Eli Lilly and Company $1273.46 -2.54% JNJ Johnson & Johnson $263.81 -1.42% ABBV AbbVie Inc. $285.64 +0.16% UNH UnitedHealth Group Incorporated Common Stock (DE) $418.09 -1.62% MRK Merck & Company, Inc. Common Stock (new) $145.27 -1.34% NVS Novartis AG $151.12 -3.30% AZN AstraZeneca PLC $171.49 -0.63% TMO Thermo Fisher Scientific Inc $673.82 -0.40% AMGN Amgen Inc. $439.26 -1.79% GILD Gilead Sciences, Inc. $156.04 -0.73% ABT Abbott Laboratories $103.70 +1.16% NVO Novo Nordisk A/S $39.05 -0.96%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens SLP currently matches

On the figures above, Simulations Plus, Inc. passes the filters for 7 of our ready-made screens, among them Small Cap Stocks, Debt Free Stocks Under $100, Debt Free Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.

Small Cap StocksDebt Free Stocks Under $100Debt Free StocksStocks Under $100Stocks Under $50Debt to Equity Below 1 StocksHigh Current Ratio Stocks

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.